Search results

103 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Nielsen published in JAMA
UNC Lineberger's Matthew E. Nielsen, MD, MS, was a co-author of an editorial in the Journal of the American Medical Association. The opinion piece, "Simplifying Treatment and Reducing Recurrence for Patients with Early-Stage Bladder Cancer," evaluated results of a randomized clinical trial testing gemcitabine after resection to prevent recurrence in bladder cancer patients.
Located in Newsletters / / Honors and Awards / 2018
Basch leads study published in JAMA Oncology
JAMA Oncology paper examined whether patients were willing to report their symptoms in multi-center clinical trials.
Located in Newsletters / / Honors and Awards / 2017
UNC Lineberger hosts Cancer Moonshoot regional summit
Members from North Carolina’s three National Cancer Institute-designated comprehensive cancer centers, together with care providers, researchers, advocates and patients from the state, met in Chapel Hill to be part of a national discussion on how to speed the pace of cancer discovery and clinical advances.
Located in News
Muss named a ‘Giant of Cancer Care’
Hyman B. Muss, MD, was honored at a ceremony in Chicago for his contributions that have advanced the fields of supportive, palliative and geriatric cancer care.
Located in News
Located in Newsroom / UNC Lineberger in the News
UNC Lineberger expands cancer survivors’ program to more N.C. locations
Through the N.C. Cancer Survivorship Provider Action Network (NC-CSPAN), cancer survivors and their loved ones can participate in a free, four-week educational program on nutrition, exercise, coping with stress and medical care. The program seeks to engage survivors to smooth the transition from active treatment.
Located in News
Chen selected for Prostate Cancer Task Force
Ronald C. Chen, MD, MPH, UNC Lineberger member and associate professor in the UNC School of Medicine, was selected to represent NRG Oncology on the Prostate Cancer Task Force, a sub-committee supporting the NCI Genitourinary Cancers Steering Committee (GUSC).
Located in Newsletters / / Honors and Awards / 2017
High up-front costs could delay access to life-saving blood cancer drugs for Medicare patients
In the study published in the Journal of Clinical Oncology, UNC Lineberger researchers report that nearly a third of a group of patients with chronic myeloid leukemia, and who have federally-funded Medicare health insurance, did not start treatment within six months of diagnosis with any of three targeted drugs that have led to dramatic improvements in survival for the disease.
Located in News
Located in Newsroom / UNC Lineberger in the News
Located in Newsroom / UNC Lineberger in the News